Latest Articles
Neuroscience Leader Neurocrine Biosciences Sets Extensive Conference Schedule with Key Executives Presenting - Stock Titan
Neuroscience Leader Neurocrine Biosciences Sets Extensive Conference Schedule with Key Executives Presenting Stock Titan
Published: Aug. 26, 2025, 8:01 p.m.
The Utah Endometriosis Center at St. Mark’s Hospital is open now to serve patients - FOX 13 News Utah
The Utah Endometriosis Center at St. Mark’s Hospital is open now to serve patients FOX 13 News Utah
Published: Aug. 26, 2025, 7:43 p.m.
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer - Oncology Nursing News
Rina-S Given Breakthrough Therapy Designation in Endometrial Cancer Oncology Nursing News
Published: Aug. 26, 2025, 6:04 p.m.
Innovative Technique for Adolescent Cervical Endometriosis Treatment - BIOENGINEER.ORG
Innovative Technique for Adolescent Cervical Endometriosis Treatment BIOENGINEER.ORG
Published: Aug. 26, 2025, 5:30 p.m.
Innovative Technique for Adolescent Cervical Endometriosis Treatment - bioengineer.org
Innovative Technique for Adolescent Cervical Endometriosis Treatment bioengineer.org
Published: Aug. 26, 2025, 5:30 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced - PharmiWeb.com
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced PharmiWeb.com
Published: Aug. 26, 2025, 4:10 p.m.
Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer - Curetoday
Rina-S Earns Breakthrough Designation in Advanced Endometrial Cancer Curetoday
Published: Aug. 26, 2025, 4:06 p.m.
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches - Frontiers
Leveraging the Role of Microbiome in Endometriosis: Novel Non-Invasive Diagnostic and Therapeutic Approaches Frontiers
Published: Aug. 26, 2025, 3:55 p.m.
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review - Frontiers
Can Bladder Endometriosis Be Hard to Diagnose? A two-case report and literature review Frontiers
Published: Aug. 26, 2025, 3:33 p.m.
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer - OncLive
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer OncLive
Published: Aug. 26, 2025, 3:01 p.m.
Link copied to clipboard!